57 results
8-K
EX-10.1
SMTI
Sanara MedTech Inc.
18 Apr 24
Sanara MedTech Inc. Announces $55 Million Debt Facility
9:20am
(and not the implied, constructive or imputed knowledge of any such Person) as of the applicable time, and without any obligation to make any independent investigation … .
(a) Litigation. There is no litigation, investigation or proceeding pending, or, to any Obligor’s Knowledge, threatened in writing, with respect
8-K
EX-10.1
SMTI
Sanara MedTech Inc.
5 Apr 24
Departure of Directors or Certain Officers
9:15am
state human rights commission, or any other governmental agency or entity; or (D) testify, assist, or participate in an investigation, hearing … investigation or proceeding conducted by the Equal Employment Opportunity Commission (“EEOC”) or a comparable state or local agency. Notwithstanding
8-K
EX-3.1
atly696 tu
22 Mar 24
Amendments to Articles of Incorporation or Bylaws
4:15pm
8-K
EX-2.1
f1rhd
2 Aug 23
Sanara MedTech Inc. Announces the Acquisition of Certain Assets Related to its Collagen Products Business
9:20am
8-K
EX-10.2
oliji3iwqsowb
2 Aug 23
Sanara MedTech Inc. Announces the Acquisition of Certain Assets Related to its Collagen Products Business
9:20am
8-K
EX-2.1
8fdwl84
5 Jul 22
Sanara MedTech Inc. Announces Closing of Scendia Biologics, LLC Acquisition
9:20am
8-K
EX-10.1
0vp5qbr3ft
29 Apr 22
Departure of Directors or Certain Officers
8:25am
8-K
EX-10.2
fns4587zp6gbg8
29 Apr 22
Departure of Directors or Certain Officers
8:25am
8-K
EX-2.1
k0zig l9x
4 Apr 22
Entry into a Material Definitive Agreement
6:34am
8-K
EX-10.1
01jrmtt 6tyyz
19 Jul 21
Sanara MedTech Inc. Announces the Purchase of Certain Assets from Rochal Industries, LLC
4:47pm
8-K
EX-1.1
1tka0o
17 Feb 21
Sanara MedTech Inc. Announces Proposed Public Offering of Common Stock
4:29pm
424B5
2kpr7oz9ujg4edw
16 Feb 21
Prospectus supplement for primary offering
4:52pm
424B5
wjdg2afff ni
11 Feb 21
Prospectus supplement for primary offering
4:06pm
8-K
EX-10.1
od7u16i
1 Feb 21
Entry into a Material Definitive Agreement
4:16pm